球脊髄性筋萎縮症治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE4020)
◆英語タイトル:Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE4020
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、球脊髄性筋萎縮症治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(5α-レダクターゼ阻害剤、ゴナドトロピン放出ホルモンアゴニスト)、用途別市場規模(病院、整形外科クリニック、外来手術センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・球脊髄性筋萎縮症治療の市場動向
・企業の競争状況、市場シェア
・球脊髄性筋萎縮症治療の種類別市場規模(5α-レダクターゼ阻害剤、ゴナドトロピン放出ホルモンアゴニスト)
・球脊髄性筋萎縮症治療の用途別市場規模(病院、整形外科クリニック、外来手術センター)
・球脊髄性筋萎縮症治療の北米市場規模2016-2027(アメリカ、カナダ)
・球脊髄性筋萎縮症治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・球脊髄性筋萎縮症治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・球脊髄性筋萎縮症治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・球脊髄性筋萎縮症治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AbbVie、Pfizer、GlaxoSmithKline、Johnson & Johnson、Century Pharmaceuticals、Astellas Pharma、Sanofi、Boehringer Ingelheim International)
・結論
【レポートの概要】

SBMA, mainly manifested as systemic muscle atrophy, paralysis and systemic muscle bundle tremor, patients with systemic muscle weakness, especially the weakness of the two lower limbs to walk, tongue muscle atrophy is usually one of the main symptoms.

Market Analysis and Insights: Global Spinal and Bulbar Muscular Atrophy Treatment Market
The global Spinal and Bulbar Muscular Atrophy Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Spinal and Bulbar Muscular Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Spinal and Bulbar Muscular Atrophy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Spinal and Bulbar Muscular Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Spinal and Bulbar Muscular Atrophy Treatment market.

Global Spinal and Bulbar Muscular Atrophy Treatment Scope and Market Size
Spinal and Bulbar Muscular Atrophy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Spinal and Bulbar Muscular Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
5α-Reductase Inhibitors
Gonadotropin-releasing Hormone Agonists

Segment by Application
Hospitals
Orthopedic Clinics
Ambulatory Surgical Centers

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Pfizer
GlaxoSmithKline
Johnson & Johnson
Century Pharmaceuticals
Astellas Pharma
Sanofi
Boehringer Ingelheim International

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 5α-Reductase Inhibitors
1.2.3 Gonadotropin-releasing Hormone Agonists
1.3 Market by Application
1.3.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Orthopedic Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Perspective (2016-2027)
2.2 Spinal and Bulbar Muscular Atrophy Treatment Growth Trends by Regions
2.2.1 Spinal and Bulbar Muscular Atrophy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Spinal and Bulbar Muscular Atrophy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Spinal and Bulbar Muscular Atrophy Treatment Industry Dynamic
2.3.1 Spinal and Bulbar Muscular Atrophy Treatment Market Trends
2.3.2 Spinal and Bulbar Muscular Atrophy Treatment Market Drivers
2.3.3 Spinal and Bulbar Muscular Atrophy Treatment Market Challenges
2.3.4 Spinal and Bulbar Muscular Atrophy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue
3.1.1 Global Top Spinal and Bulbar Muscular Atrophy Treatment Players by Revenue (2016-2021)
3.1.2 Global Spinal and Bulbar Muscular Atrophy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Spinal and Bulbar Muscular Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Spinal and Bulbar Muscular Atrophy Treatment Revenue
3.4 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio
3.4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal and Bulbar Muscular Atrophy Treatment Revenue in 2020
3.5 Spinal and Bulbar Muscular Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Spinal and Bulbar Muscular Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Spinal and Bulbar Muscular Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Type
4.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Type (2022-2027)

5 Spinal and Bulbar Muscular Atrophy Treatment Breakdown Data by Application
5.1 Global Spinal and Bulbar Muscular Atrophy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Spinal and Bulbar Muscular Atrophy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
6.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
6.2.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
6.2.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
6.2.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
6.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
6.3.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
6.3.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
6.3.3 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
6.4 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
6.4.1 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
6.4.2 North America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
7.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
7.2.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
7.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
7.3.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
7.4 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
7.4.1 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Spinal and Bulbar Muscular Atrophy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
9.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
9.2.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
9.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
9.3.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
9.4 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
9.4.1 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Spinal and Bulbar Muscular Atrophy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.1.4 AbbVie Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.2.4 Pfizer Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Century Pharmaceuticals
11.5.1 Century Pharmaceuticals Company Details
11.5.2 Century Pharmaceuticals Business Overview
11.5.3 Century Pharmaceuticals Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.5.4 Century Pharmaceuticals Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.5.5 Century Pharmaceuticals Recent Development
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Details
11.6.2 Astellas Pharma Business Overview
11.6.3 Astellas Pharma Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.6.4 Astellas Pharma Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.6.5 Astellas Pharma Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.7.4 Sanofi Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Boehringer Ingelheim International
11.8.1 Boehringer Ingelheim International Company Details
11.8.2 Boehringer Ingelheim International Business Overview
11.8.3 Boehringer Ingelheim International Spinal and Bulbar Muscular Atrophy Treatment Introduction
11.8.4 Boehringer Ingelheim International Revenue in Spinal and Bulbar Muscular Atrophy Treatment Business (2016-2021)
11.8.5 Boehringer Ingelheim International Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 球脊髄性筋萎縮症治療の世界市場規模・現状・予測2021年-2027年(Global Spinal and Bulbar Muscular Atrophy Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。